{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:27:55Z","timestamp":1791473275213,"version":"4.3.4"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1681\/asn.2010111210","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T22:16:12Z","timestamp":1319235372000},"page":"86-102","source":"Crossref","is-referenced-by-count":346,"title":["Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy"],"prefix":"10.1681","volume":"23","author":[{"given":"Miao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Han","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao Jia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta Y.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.K.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wo Shing","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Wah","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar Neng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney C.W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20230208","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic.","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"R2-15-20230208","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2007091048","article-title":"The role of inflammatory cytokines in diabetic nephropathy.","volume":"19","author":"Navarro-Gonz\u00e1lez","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R3-15-20230208","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/diab.43.8.1046","article-title":"Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria.","volume":"43","author":"Taft","year":"1994","journal-title":"Diabetes"},{"key":"R4-15-20230208","first-page":"S283","article-title":"Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future.","volume":"10","author":"Mackenzie","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R6-15-20230208","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature02761","article-title":"Inferences, questions and possibilities in Toll-like receptor signalling.","volume":"430","author":"Beutler","year":"2004","journal-title":"Nature"},{"key":"R7-15-20230208","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI31008","article-title":"TLR4 activation mediates kidney ischemia\/reperfusion injury.","volume":"117","author":"Wu","year":"2007","journal-title":"J Clin Invest"},{"key":"R8-15-20230208","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ki.2010.381","article-title":"Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury.","volume":"79","author":"Chen","year":"2011","journal-title":"Kidney Int"},{"key":"R9-15-20230208","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.172.4.2629","article-title":"Role of Toll-like receptor 4 in endotoxin-induced acute renal failure.","volume":"172","author":"Cunningham","year":"2004","journal-title":"J Immunol"},{"key":"R10-15-20230208","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1523-1755.2005.00354.x","article-title":"Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.","volume":"67","author":"Ducloux","year":"2005","journal-title":"Kidney Int"},{"key":"R11-15-20230208","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1073\/pnas.0810169106","article-title":"Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation.","volume":"106","author":"Kr\u00fcger","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-15-20230208","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1681\/ASN.2009070722","article-title":"TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury.","volume":"21","author":"Pulskens","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R13-15-20230208","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2006060634","article-title":"Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2.","volume":"18","author":"Brown","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R14-15-20230208","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/ki.2010.327","article-title":"Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis.","volume":"78","author":"Summers","year":"2010","journal-title":"Kidney Int"},{"key":"R15-15-20230208","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1681\/ASN.2004100820","article-title":"Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.","volume":"16","author":"Patole","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R16-15-20230208","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2006030263","article-title":"Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.","volume":"17","author":"Pawar","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R17-15-20230208","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1681\/ASN.2005070714","article-title":"Toll-like receptor-7 modulates immune complex glomerulonephritis.","volume":"17","author":"Pawar","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R18-15-20230208","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance.","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"key":"R19-15-20230208","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db08-0038","article-title":"Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.","volume":"57","author":"Reyna","year":"2008","journal-title":"Diabetes"},{"key":"R20-15-20230208","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00125-009-1394-8","article-title":"Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes.","volume":"52","author":"Devaraj","year":"2009","journal-title":"Diabetologia"},{"key":"R21-15-20230208","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc09-1799","article-title":"Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.","volume":"33","author":"Dasu","year":"2010","journal-title":"Diabetes Care"},{"key":"R22-15-20230208","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1681\/ASN.2005101113","article-title":"Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.","volume":"17","author":"Tang","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R23-15-20230208","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10096-010-0985-0","article-title":"Association of genetic polymorphisms in the IL12-IFNG pathway with susceptibility to and prognosis of pulmonary tuberculosis in a Chinese population.","volume":"29","author":"Wang","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R24-15-20230208","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI16079","article-title":"Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo.","volume":"111","author":"Tang","year":"2003","journal-title":"J Clin Invest"},{"key":"R25-15-20230208","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/157339908783502361","article-title":"Role of inflammation in diabetic nephropathy.","volume":"4","author":"Fornoni","year":"2008","journal-title":"Curr Diabetes Rev"},{"key":"R26-15-20230208","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1523-1755.1999.00721.x","article-title":"The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?","volume":"56","author":"Gilbert","year":"1999","journal-title":"Kidney Int"},{"key":"R27-15-20230208","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity.","volume":"2","author":"Akira","year":"2001","journal-title":"Nat Immunol"},{"key":"R28-15-20230208","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1681\/ASN.2005111167","article-title":"Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis.","volume":"17","author":"Brown","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R29-15-20230208","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1172\/JCI22832","article-title":"Renal-associated TLR2 mediates ischemia\/reperfusion injury in the kidney.","volume":"115","author":"Leemans","year":"2005","journal-title":"J Clin Invest"},{"key":"R30-15-20230208","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000317023","article-title":"Increased expression of toll-like receptor 2 in rat diabetic nephropathy.","volume":"32","author":"Li","year":"2010","journal-title":"Am J Nephrol"},{"key":"R31-15-20230208","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.4049\/jimmunol.178.10.6252","article-title":"TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways.","volume":"178","author":"Shigeoka","year":"2007","journal-title":"J Immunol"},{"key":"R32-15-20230208","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2119\/2008-00034.Klune","article-title":"HMGB1: endogenous danger signaling.","volume":"14","author":"Klune","year":"2008","journal-title":"Mol Med"},{"key":"R33-15-20230208","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.2009101048","article-title":"HMGB1 contributes to kidney ischemia reperfusion injury.","volume":"21","author":"Wu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R34-15-20230208","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1189\/jlb.1209775","article-title":"Endogenous ligands of TLR2 and TLR4: agonists or assistants?","volume":"87","author":"Erridge","year":"2010","journal-title":"J Leukoc Biol"},{"key":"R35-15-20230208","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ndt\/gfp599","article-title":"Bradykinin and high glucose promote renal tubular inflammation.","volume":"25","author":"Tang","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R36-15-20230208","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cellsig.2004.08.005","article-title":"Involvement of PKCalpha\/beta in TLR4 and TLR2 dependent activation of NF-kappaB.","volume":"17","author":"Asehnoune","year":"2005","journal-title":"Cell Signal"},{"key":"R37-15-20230208","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/db08-0564","article-title":"High glucose induces toll-like receptor expression in human monocytes: mechanism of activation.","volume":"57","author":"Dasu","year":"2008","journal-title":"Diabetes"},{"key":"R38-15-20230208","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1681\/ASN.2005070699","article-title":"Angiotensin II upregulates toll-like receptor 4 on mesangial cells.","volume":"17","author":"Wolf","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R39-15-20230208","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000102551","article-title":"Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites.","volume":"27","author":"Bondeva","year":"2007","journal-title":"Am J Nephrol"},{"key":"R40-15-20230208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbrc.2009.01.035","article-title":"Candesartan attenuates angiotensin II-induced mesangial cell apoptosis via TLR4\/MyD88 pathway.","volume":"380","author":"Lv","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"R41-15-20230208","first-page":"280","article-title":"[Effect of spironolactone on the expression of Toll-like receptor 4 in renal tubular epithelia cells exposed to high glucose]","volume":"12","author":"Liu","year":"2010","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R42-15-20230208","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1152\/ajpendo.00490.2010","article-title":"Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.","volume":"300","author":"Dasu","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R43-15-20230208","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","article-title":"MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.","volume":"294","author":"Tesch","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R44-15-20230208","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000188281","article-title":"Detection of serum IL-6 in patients with diabetic nephropathy.","volume":"68","author":"Sekizuka","year":"1994","journal-title":"Nephron"},{"key":"R45-15-20230208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.ki.5000014","article-title":"Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.","volume":"69","author":"Chow","year":"2006","journal-title":"Kidney Int"},{"key":"R46-15-20230208","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00125-006-0497-8","article-title":"Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db\/db mice.","volume":"50","author":"Chow","year":"2007","journal-title":"Diabetologia"},{"key":"R47-15-20230208","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1995.437","article-title":"Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells.","volume":"48","author":"Prodjosudjadi","year":"1995","journal-title":"Kidney Int"},{"key":"R48-15-20230208","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/01.ASN.0000015609.31253.7F","article-title":"MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1.","volume":"13","author":"Viedt","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R49-15-20230208","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ki.5000206","article-title":"Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling.","volume":"69","author":"Hsieh","year":"2006","journal-title":"Kidney Int"},{"key":"R50-15-20230208","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ndt\/17.6.985","article-title":"Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.","volume":"17","author":"Kelly","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R51-15-20230208","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1475-2840-9-90","article-title":"Enhanced inflammatory responses to toll-like receptor 2\/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin.","volume":"9","author":"Li","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"R52-15-20230208","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/CIRCRESAHA.106.142851","article-title":"Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity.","volume":"100","author":"Kim","year":"2007","journal-title":"Circ Res"},{"key":"R53-15-20230208","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diabetes.54.9.2628","article-title":"Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.","volume":"54","author":"Qi","year":"2005","journal-title":"Diabetes"},{"key":"R54-15-20230208","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/labinvest.2011.81","article-title":"Additive renoprotective effects of B2-kinin receptor blocker and PPAR-\u03b3 agonist in uninephrectomized db\/db mice.","volume":"91","author":"Tang","year":"2011","journal-title":"Lab Invest"},{"key":"R55-15-20230208","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000316056","article-title":"Renoprotection by rosiglitazone in accelerated type 2 diabetic nephropathy: Role of STAT1 inhibition and nephrin restoration.","volume":"32","author":"Tang","year":"2010","journal-title":"Am J Nephrol"},{"key":"R56-15-20230208","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ndt\/gfn573","article-title":"Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.","volume":"24","author":"Kamijo-Ikemori","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R57-15-20230208","first-page":"351","article-title":"Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db\/db mice. An accelerated model of advanced diabetic nephropathy.","volume":"12","author":"Ninichuk","year":"2007","journal-title":"Eur J Med Res"},{"key":"R58-15-20230208","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s11095-008-9571-x","article-title":"Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases.","volume":"25","author":"Leon","year":"2008","journal-title":"Pharm Res"},{"key":"R59-15-20230208","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2007.06.027","article-title":"Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model.","volume":"571","author":"Sha","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"R60-15-20230208","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/367990","article-title":"Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia.","volume":"187","author":"Lynn","year":"2003","journal-title":"J Infect Dis"},{"key":"R61-15-20230208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-1759(98)00016-7","article-title":"Rapid fluorescence-based measurement of neutrophil migration in vitro.","volume":"213","author":"Frevert","year":"1998","journal-title":"J Immunol Methods"},{"key":"R62-15-20230208","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R63-15-20230208","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201201000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:25:30Z","timestamp":1786130730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201201000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2010111210","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}